News

News
JNJ Press releases

Janssen Announces Exclusive, Worldwide License Agreement With Arrowhead Pharmaceuticals to Develop and Commercialize a New Treatment for Chronic Hepatitis B Viral Infection

Read full story
JNJ Press releases

Johnson & Johnson Innovation Announces Winners of the Victorian QuickFire Challenge in Collaboration with Victorian Government

Read full story
JNJ Press releases

Johnson & Johnson Medical Korea Ltd. and Johnson & Johnson Innovation Announce Launch of Seoul Innovation QuickFire Challenge: Robotics & Digital Surgery in Collaboration with Seoul Metropolitan Government and KHIDI

Read full story
JNJ Press releases

EUSA PHARMA ANNOUNCES ACQUISITION OF GLOBAL RIGHTS TO SYLVANT® (SILTUXIMAB) FROM JANSSEN SCIENCES IRELAND UC FOR $115 MILLION

Read full story
JNJ Press releases

Johnson & Johnson Innovation Announces Memorandum of Understanding with Kyoto University to Collaborate in Identifying and Accelerating the Development of Innovative Healthcare Solutions

Read full story
JNJ Press releases

Johnson & Johnson Innovation Opens JLABS @ NYC in Collaboration with New York State and the New York Genome Center

Read full story
JNJ Press releases

Johnson & Johnson Innovation Announces Launch of Shanghai Lung Cancer Innovation QuickFire Challenge

Read full story
JNJ Press releases

Johnson & Johnson Innovation Announces Five-Year Alliance with Boston University to Accelerate Vision of World Without Lung Cancer

Read full story
JNJ Press releases

VIVUS Executes on its Strategic Vision with the Closing of its Acquisition of PANCREAZE® and Previously Announced Financing Transaction

Read full story
JNJ Press releases

James Allison, Ph.D., Wins 2018 Dr. Paul Janssen Award for Biomedical Research

Read full story
JNJ Press releases

Zebra Medical Vision raises $30 million

Read full story
JNJ Press releases

GCV Powerlist 2018: #5 Tom Heyman

Read full story
JNJ Press releases

Janssen to Acquire BeneVir Biopharm to Advance Immunotherapy Regimen

Read full story
JNJ Press releases

Janssen to Acquire BeneVir Biopharm to Advance Immunotherapy Regimen

Read full story
JNJ Press releases

Janssen Announces Worldwide Development and Commercialization Collaboration with Bristol-Myers Squibb to Advance a Next-Generation Therapy for Cardiovascular Diseases

Read full story